1. Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy.
- Author
-
Dekeyser, Manon, de Goër de Herve, Marie-Ghislaine, Hendel-Chavez, Houria, Labeyrie, Célin, Adams, David, Nasser, Ghaïdaa Adebs, Gasnault, Jacques, Durrbach, Antoine, and Taoufik, Yassine
- Subjects
- *
T cells , *PROGRESSIVE multifocal leukoencephalopathy , *POLYOMAVIRUSES - Abstract
rogressive multifocal leukoencephalopathy (PML) is a deadly demyelinating disease due to central nervous system replication of the human polyomavirus JC virus (JCV) in immunosuppressed patients. The only effective therapeutic approach is to restore anti-JCV T-cell responses. In this study, we describe a case of rapidly fatal PML with JCV T-cell anergy in a renal transplant patient treated with CTLA4-Ig (belatacept, a CD28-B7 costimulation blocker and T-cell anergy inducer). T-cell anergy could not be reversed despite several therapeutic approaches. Progressive multifocal leukoencephalopathy secondary to biotherapy-induced T-cell anergy may thus represent a subset of PML with major resistance to anti-JCV immune recovery [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF